Eric P Krenning Selected Research

Eric P Krenning Research Topics

Disease

86	Neoplasms (Cancer) 02/2024 - 04/2002
34	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 04/2002
13	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2002
8	Thyroid Neoplasms (Thyroid Cancer) 02/2016 - 06/2002
6	Prostatic Neoplasms (Prostate Cancer) 03/2019 - 01/2007
4	Carcinoid Tumor (Carcinoid) 04/2008 - 08/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2013
3	Diabetes Mellitus 05/2010 - 06/2003
3	Proteinuria 05/2007 - 04/2002
3	Pituitary Neoplasms (Pituitary Adenoma) 04/2007 - 12/2003
3	Breast Neoplasms (Breast Cancer) 04/2004 - 03/2003
2	Disease Progression 01/2022 - 12/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 01/2007
2	Diarrhea 03/2021 - 09/2011
2	Adenocarcinoma 10/2020 - 06/2007
2	Colonic Neoplasms (Colon Cancer) 10/2020 - 06/2020
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017 - 05/2016
2	Gastro-enteropancreatic neuroendocrine tumor 05/2014 - 09/2010
2	Vomiting 09/2011 - 01/2003
2	Renal Insufficiency (Renal Failure) 12/2010 - 01/2007
2	Hypertension (High Blood Pressure) 05/2010 - 04/2002
2	Hodgkin Disease (Hodgkin's Disease) 06/2009 - 04/2003
2	Carcinoma (Carcinomatosis) 04/2008 - 10/2006
2	Pheochromocytoma 04/2008 - 01/2007
2	Paraganglioma (Paragangliomas) 01/2007 - 10/2006
2	Melanoma (Melanoma, Malignant) 10/2006 - 12/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2006 - 08/2002
2	Lymphatic Metastasis 04/2004 - 03/2003
2	Cardiomyopathies (Cardiomyopathy) 06/2003 - 09/2002
1	Inflammation (Inflammations) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	COVID-19 01/2022
1	Cytokine Release Syndrome 01/2022
1	Flushing 03/2021

Drug/Important Bio-Agent (IBA)

38	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2024 - 04/2002
36	Radioisotopes (Radionuclides)IBA 02/2024 - 04/2002
36	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2024 - 04/2002
26	Peptide Receptors (Peptide Receptor)IBA 01/2020 - 12/2002
23	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2022 - 04/2002
21	Peptides (Polypeptides)IBA 11/2020 - 12/2002
20	Octreotide (Sandostatin)FDA LinkGeneric 12/2021 - 04/2002
18	Pentetic Acid (DTPA)FDA LinkGeneric 05/2014 - 04/2002
14	Tyr(3)- octreotateIBA 11/2015 - 04/2002
12	Bombesin Receptors (Bombesin Receptor)IBA 11/2020 - 01/2007
11	BombesinIBA 03/2019 - 12/2002
10	Neprilysin (Neutral Endopeptidase)IBA 11/2020 - 01/2014
8	AcidsIBA 04/2008 - 12/2002
7	phosphoramidonIBA 11/2020 - 01/2014
7	3-Tyr-octreotideIBA 03/2010 - 04/2002
6	NeurotensinIBA 10/2023 - 01/2005
6	Cholecystokinin (Pancreozymin)IBA 03/2022 - 07/2009
6	GastrinsIBA 03/2022 - 07/2009
5	Lysine (L-Lysine)FDA Link 11/2014 - 12/2005
5	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 03/2010 - 01/2005
5	RadiopharmaceuticalsIBA 07/2009 - 04/2002
4	lutetium Lu 177 dotatateIBA 12/2021 - 05/2014
4	Gastrin-Releasing PeptideIBA 11/2013 - 12/2002
4	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011 - 08/2007
4	pentetreotide (OctreoScan)FDA Link 05/2010 - 04/2003
4	177Lu-octreotateIBA 08/2007 - 10/2003
3	minigastrinIBA 02/2016 - 03/2003
3	Amifostine (Ethyol)FDA LinkGeneric 05/2012 - 01/2007
3	Amino Acids FDA Link 12/2010 - 04/2002
3	CreatinineIBA 05/2007 - 04/2002
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 04/2007 - 12/2003
3	Therapeutic UsesIBA 07/2004 - 04/2002
2	hydroxide ionIBA 10/2023 - 06/2007
2	Chelating AgentsIBA 03/2022 - 10/2003
2	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2020 - 10/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 06/2020
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020 - 06/2020
2	Lisinopril (Prinivil)FDA LinkGeneric 10/2020 - 06/2020
2	Vasopeptidase InhibitorsIBA 10/2020 - 12/2016
2	68Ga-SB3IBA 03/2019 - 01/2017
2	Chromogranin AIBA 01/2018 - 09/2011
2	Arginine (L-Arginine)FDA Link 12/2010 - 12/2005
2	Hormones (Hormone)IBA 09/2010 - 04/2008
2	AndrogensIBA 06/2010 - 01/2007
2	Substance PIBA 07/2009 - 01/2005
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2009 - 04/2008
2	indium-111-octreotideIBA 07/2009 - 01/2005
2	Folic Acid AntagonistsIBA 04/2008 - 08/2007
2	Pemetrexed (MTA)FDA Link 04/2008 - 08/2007
2	Dobutamine FDA LinkGeneric 01/2006 - 09/2002
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2006 - 06/2003
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2006 - 08/2002
2	Cholecystokinin B ReceptorIBA 04/2004 - 03/2003
1	neurotensin (8-13)IBA 10/2023
1	AminesIBA 10/2023
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 03/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Purinergic Receptors (Receptors, Purine)IBA 01/2022

Therapy/Procedure

51	Therapeutics 02/2024 - 04/2002
9	Aftercare (After-Treatment) 07/2020 - 04/2003
8	Precision Medicine 02/2024 - 01/2017
8	Radiotherapy 01/2018 - 12/2002
7	Drug Therapy (Chemotherapy) 01/2018 - 08/2002
2	Castration 06/2010 - 01/2007